Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial

被引：0
|
作者：
Jeremy Pettus
Schafer C. Boeder
Mark P. Christiansen
Douglas S. Denham
Timothy S. Bailey
Halis K. Akturk
Leslie J. Klaff
Julio Rosenstock
Mickie H. M. Cheng
Bruce W. Bode
Edgar D. Bautista
Ren Xu
Hai Yan
Dung Thai
Satish K. Garg
Samuel Klein
机构：
[1] University of California San Diego,Division of Endocrinology
[2] Diablo Clinical Research,Barbara Davis Center for Diabetes
[3] Clinical Trials of Texas,Center for Human Nutrition
[4] AMCR Institute,undefined
[5] University of Colorado Anschutz Campus,undefined
[6] Rainier Clinical Research Center,undefined
[7] Dallas Diabetes Research Center,undefined
[8] Marin Endocrine Care and Research,undefined
[9] Atlanta Diabetes Associates,undefined
[10] REMD Biotherapeutics,undefined
[11] Washington University School of Medicine,undefined
[12] St. Louis,undefined
[13] MO and Sansum Diabetes Research Institute,undefined
来源：
Nature Medicine | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2959 / 2959
相关论文
共 50 条
  • [41] Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial
    Pan, C.
    Yang, W.
    Barona, J. P.
    Wang, Y.
    Niggli, M.
    Mohideen, P.
    Wang, Y.
    Foley, J. E.
    DIABETIC MEDICINE, 2008, 25 (04) : 435 - 441
  • [42] Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes - A 24-week, double-blind, randomized trial
    Rosenstock, Julio
    Mills, David
    Baron, Michelle A.
    Schweizer, Anja
    Dejager, Sylvie
    DIABETES CARE, 2007, 30 (02) : 217 - 223
  • [43] Crossover, Double-Blind, Unicentric, 52-Week Trial of Liraglutide in Type 1 Diabetes
    Dube, Marie-Christine
    D'Amours, Martin
    Weisnagel, S. John
    DIABETES, 2016, 65 : A76 - A77
  • [44] Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: A 12-week, randomized, double-blind, placebo-controlled trial
    Malhotra, AK
    Keefe, R
    Meltzer, H
    Kane, J
    Murthy, A
    Sovel, M
    Xu, YK
    Gold, L
    Goldman, R
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S171 - S171
  • [45] Preventing poststroke depression: A 12-week double-blind randomized treatment trial and 21-month follow-up
    Narushima, K
    Kosier, JT
    Robinson, RG
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2002, 190 (05) : 296 - 303
  • [46] Effects of Aloe Sterol Supplementation on Skin Elasticity, Hydration, and Collagen Score: A 12-Week Double-Blind, Randomized, Controlled Trial
    Tanaka, Miyuki
    Yamamoto, Yuki
    Misawa, Eriko
    Nabeshima, Kazumi
    Saito, Marie
    Yamauchi, Koji
    Abe, Fumiaki
    Furukawa, Fukumi
    SKIN PHARMACOLOGY AND PHYSIOLOGY, 2016, 29 (06) : 309 - 317
  • [47] Efficacy and safety of the glucagon receptor antagonist volagidemab in type-1 diabetes: A systematic review and meta-analysis
    Dutta, Deep
    Kamrul-Hasan, A. B. M.
    Surana, Vineet
    Singla, Rajiv
    Khandelwal, Deepak
    Aggarwal, Sameer
    Nagendra, Lakshmi
    Bhattacharya, Saptarshi
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2025, 1543 (01) : 94 - 101
  • [48] Efficacy and safety of the glucagon receptor antagonist PF-06291874: A 12-week, randomized, dose-response study in patients with type 2 diabetes mellitus on background metformin therapy
    Kazierad, David J.
    Chidsey, Kristin
    Somayaji, Veena R.
    Bergman, Arthur J.
    Calle, Roberto A.
    DIABETES OBESITY & METABOLISM, 2018, 20 (11): : 2608 - 2616
  • [49] Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4-week, double-blind, randomized, placebo-controlled phase 2 trial
    Shimada, Akira
    Hanafusa, Toshiaki
    Yasui, Atsutaka
    Lee, Ganghyuck
    Taneda, Yusuke
    Sarashina, Akiko
    Shiki, Kosuke
    George, Jyothis
    Soleymanlou, Nima
    Marquard, Jan
    DIABETES OBESITY & METABOLISM, 2018, 20 (09): : 2190 - 2199
  • [50] Creatine in Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
    Gualano, Bruno
    Painneli, Vitor De Salles
    Roschel, Hamilton
    Artioli, Guilherme Giannini
    Neves, Manoel, Jr.
    De Sa Pinto, Ana Lucia
    Rossi Da Silva, Maria Elizabeth
    Cunha, Maria Rosaria
    Garcia Otaduy, Maria Concepcion
    Leite, Claudia Da Costa
    Ferreira, Julio Cesar
    Pereira, Rosa Maria
    Brum, Patricia Chakur
    Bonfa, Eloisa
    Lancha, Antonio Herbert, Jr.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2011, 43 (05): : 770 - 778
12345